Grifols cleared plasma donors despite disease-risk concerns: Health Canada A new Health Canada report found multiple cases in which private blood products company Grifols cleared people to donate plasma who should have been turned away because of risks linked to mad cow disease, a fatal brain disorder
Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
With semaglutide, patients can achieve an average weight loss of 15% of their body weight, as demonstrated in clinical trials, making it a significantly more effective option compared to other weight loss medications currently available
Side Effects and What to Expect Most common side effects I see: Nausea Constipation Fullness Temporary fatigue These are usually manageable with: Slower dose increases Protein-first meals Adequate hydration Ongoing medical monitoring Why Medical Supervision Matters Using semaglutide without medical oversight increases the risk of: Improper dosing Nutritional deficiencies Poor side effect management Suboptimal long-term outcomes At Florida Surgery & Weight Loss Center , we monitor: Weight trends Metabolic labs Medication tolerance Nutritional intake Long-term response This approach improves both safety and results
These benefits may be attributed to improved glycemic control, weight loss, reduced inflammation, and direct effects on blood vessels and the heart
Semaglutide suppresses appetite by mimicking the GLP-1 hormone, which activates receptors in the brain
